Our study revealed that the genetic variations of 22 TFs were significantly associated with breast cancer risk and highlighted genetic variations of TF–DNA bindings (particularly for FOXA1) underlying breast cancer susceptibility (16). This evidence concerns the gene TF and breast carcinoma.